Investigating the health care situation of cholinergic urticaria patients

• Conditions: L50.5; Cholinergic urticaria

• Registration Number: DRKS00012387
• Lead Sponsor: Charite-Universitätsmedizin Berlin, Klinik für Dermatologie und Allergologie

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2017-06-06
• Study Completion: 2018-08-01
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 325

Inclusion Criteria

Subproject 1: All patient records were selected from patients who visited and were treated by the allergy center within the course of urticaria consultation hours of the Charite-Universitätsmedizin Berlin due to cholinergic urticaria between December 2005 and July 2015.
Subproject 2: All adult patients suffering from cholinergic urticaria, may participate.

Exclusion Criteria

Subproject 2: minors

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The aim of this project is to investigate the journey of patients suffering from cholinergic urticaria in the medical health care system in Germany.

Secondary Outcome Measures

Name	Time	Method
Step1: retrospective assessement of disease severity and clinical characteristics and past therapeutic interventions.<br><br>Step2: detailed analysis of the use of the medical health care system of patients with different grade of disease severity, descriptive